On January 6, 2026, Medable announced that it will unveil the Trial Master File (TMF) AI agent at a trade show that automates the labor-intensive processes involved in clinical trial document management.
Based on Medable's Agent Studio, an agent AI platform for clinical development, the TMF Agency autonomously ingests documents, categorizes files, and extracts metadata to “tailor TMF workflows end-to-end” (1). These data are prepared for human review before being sent with one click to commonly used eTMF systems (Veeva Vault, Wingspan, OpenText, etc.). AI agents are system agnostic and can be integrated into existing workflows. Human checkpoints enable verification, quality control, and audit traceability.
“We are applying AI to improve quality, eliminate bottlenecks in clinical development, and free up highly skilled developers to perform more strategic work to advance clinical development,” states a press release (1). “Medable agents make clinical trial systems work smarter by removing the friction between document management and regulatory submissions. We continue to build agents that address the toughest clinical trial challenges, while also enabling our customers to use Studio to build their own agents.”
How diverse is the use of AI in pharmaceutical development?
The use of AI and machine learning is rapidly advancing in the pharmaceutical industry. Regulatory agency staff are also taking advantage of this new technology. In December 2025,
“FDA's talented reviewers have been creative and proactive in implementing AI capabilities, and Agent AI provides a powerful tool to streamline the work of reviewers and ensure the safety and effectiveness of regulated products,” Chief AI Officer Jeremy Walsh said in a press release (2).
In June 2025,
“Following the great success of our pilot program with FDA's scientific reviewers, we have set an aggressive timeline to scale AI agency-wide by June 30,” McCurry said in a press release at the time. “Today's Elsa deployment was completed ahead of schedule and on budget thanks to the collaboration of our in-house experts across each center.”
References
- Medable. Medable launches new AI agent to automate clinical trial document management, speaks at JPM Health. press release. January 6, 2026.
- F.D.A. FDA expands the capabilities of artificial intelligence with the introduction of agent-based AI. press release. December 1, 2025.
https://www.fda.gov/news-events/press-payments/fda-expands-artificial-intelligence-capabilities-agentic-ai-deployment - F.D.A. FDA launches agency-wide AI tool to optimize performance for Americans. press release. June 2, 2025.
https://www.fda.gov/news-events/press-payments/fda-launches-agency-wide-ai-tool-optimize-performance-american-people
